The Tennessee Alcoholic Beverage Commission (TABC) recently released initial guidance on Public Chapter 526, which Governor Lee signed on May 21. The new law makes important changes to how ...

Jim Herlihy, a regional spokesman for the Alzheimer’s Association, will tell you that Kocherhans finds himself in good, if ...

Caregivers of people diagnosed with early onset Alzheimer's disease have called on Congress to end its two year waiting ...

Highlight brain imaging analysis solutions, including 'Neurophet AQUA AD', which monitors side effects from Alzheimer's ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST ...

Reimagining Alzheimer's care in Canada is not just important for the system—it is imperative for all Canadians. We owe it to those affected to provide the dignity and quality of life they deserve. The ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $190.82, a high estimate of ...

Two new drugs targeting early-stage Alzheimer’s disease are expected to be put into clinical use as soon as Thursday next ...

A new Fujirebio Diagnostics blood test identifies beta-amyloid, a brain plaque that is a key marker for Alzheimer’s disease.

A Chinese company that developed the country’s first indigenous therapy for Alzheimer’s disease has suspended production and ...

NewAmsterdam Pharma has said that an oral drug it is developing to lower cholesterol has shown preliminary efficacy as a ...

See here for Eisai (ESALF) stock analysis including Leqembi's EU approval, growth potential, and industry valuation amid ...